| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |